Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine in HIPEC cytoreductive surgery
NCT03370588Completed
- Sponsor
- Yonsei University
- Start
- Dec 2017
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in colon cancer comparing Dexmedetomidine with Placebo (2 arms). Primary endpoint: Interleukin-6 level. Started Dec 2017; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT03370588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03370588.